• There are no suggestions because the search field is empty.
CH-REP - Regulatory Affairs - QbD Group (2)

Swiss Authorised Representative (CH-REP) Services

Placing medical devices or IVDs on the Swiss market? You need a Swiss Authorised Representative (CH-REP). QbD Group helps non-Swiss manufacturers meet MedDO and IvDO requirements and ensures your products comply with Swiss regulations. Ensure compliant entry into Switzerland with confidence.
 
Since Switzerland is not part of the EU regulatory framework, manufacturers based outside Switzerland must appoint a Swiss Authorised Representative (CH-REP) to place medical devices and IVDs on the Swiss market. This obligation is outlined in the Swiss Medical Devices Ordinance (MedDO, SR 812.213) and the In Vitro Diagnostic Medical Devices Ordinance (IvDO, SR 812.219).
 
Qarad Suisse S.A. – part of the QbD Group – brings over 20 years of experience in MD and IVD representation as an EU and UK authorized representative. Operating from Switzerland, our dedicated team combines strong regulatory and technical expertise to ensure full Swissmedic compliance. We act as your reliable CH-REP throughout the entire product lifecycle.

 

What is a CH-REP and who needs one?

A Swiss Authorised Representative (CH-REP) is a natural or legal person based in Switzerland who acts on behalf of a non-Swiss manufacturer. The CH-REP ensures your device meets Swiss regulatory obligations, communicates with Swissmedic, and keeps documentation audit-ready.

Manufacture medical devices or IVDs outside of Switzerland

Want to sell devices in Switzerland post-MRA update

Require local representation for compliance with MedDO and IvDO

CH-REP - Regulatory Affairs - QbD Group

How can we help you as a CH-REP?

Qarad Suisse S.A. ensures compliance through local representation and direct communication with Swissmedic. We act as your reliable partner throughout the entire lifecycle of your device.

Our Role as Your Swiss Authorised Representative As your CH-REP, we will:

  • Verify your Declaration of Conformity and technical documentation

  • Retain copies of your technical documentation and certificates for at least 10 years

  • Provide Swissmedic with documentation upon request

  • Ensure your product registration and labelling meet Swiss requirements

  • Submit documentation to Swissmedic if required and meet any deadlines

  • Communicate and act on Swissmedic requests for corrective actions, product information, or complaints

doc-mask

Our 3-step onboarding process

News  - QbD Group announces acquisition of SciencePharma, strengthening global regulatory and quality expertise - QbD Group

1. Mandate & setup

We sign your CH-REP agreement and assess your documentation.

External newsletters rechthoek (2)-1

Regulatory check

We verify compliance with Swiss-specific requirements.

CH-REP - Regulatory Affairs - QbD Group (2)

Official representation

We act on your behalf with Swissmedic and maintain your audit readiness.

Offering_Regulatory 1
CH-REP - Regulatory Affairs - QbD Group

Why partner with QbD Group?

  • Proven experience: Over 20 years of trusted representation across Europe and Switzerland

  • Regulatory experts: Skilled in Swiss regulations and experienced in Swissmedic communication

  • Independent partner: We maintain separation from your importer or distributor

  • EU alignment: We work according to MDR/IVDR principles, easing dual-market strategies

  • Trusted by leading manufacturers: Over 100 companies worldwide rely on us

CH-REP Frequently Asked Questions

Is CH-REP similar to an EU-REP?

Yes, the CH-REP mirrors the EU-REP role in terms of scope and responsibilities, adapted to Swiss national laws.

Should CH-REP details appear on labelling?

Yes, the CH-REP data must be added to the device. Depending on the class of the medical device, the CH-REP details must be included on the label and/or in the instructions for use or in a document accompanying the device. Deadlines for adding the CH-REP details also depend on the class of the device.

Can one partner support both EU and Swiss requirements?

Absolutely. QbD Group covers EU-REP, UKRP, and CH-REP needs through one integrated team.

According to the MDR, I have older devices for which I have a valid certificate from a notified body. Do I need to designate a CH-REP for these devices as well to access the Swiss market?

All other foreign manufacturers must designate a Swiss Authorized Representative effective May 26, 2021. These provisions apply to both MDD/AIMDD and MDR devices.

 

 

contact-mail

Get in touch

Get in touch with our CH-REP experts

Want a reliable Swiss representative to secure your market access? QbD Group is ready to support your regulatory journey. Contact us for more information or request a free, no-obligation proposal.

RA_Get in touch

Authorized Representative Services for the EU and UK

Do you want to appoint an Authorised Representative to sell your products in the UK or the EU? 

Find out more about our European and UK representative services:

Authorized-Representative-EC-REP-QbD-Group

EU-REP

When you are a manufacturer that wants to enter Europe.
UK-Responsible-Person-UKRP-QbD-Group

UKRP

If you are a manufacturer that wants to enter the United Kingdom.

Related content

preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.